Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DECREASED SENSITIVITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McGrath, MT
      Fungicide resistance in cucurbit powdery mildew: Experiences and challenges

      PLANT DISEASE
    2. Penn, CR; Osterhaus, A
      Zanamivir: A rational approach to influenza B

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    3. Tisdale, M
      Monitoring of viral susceptibility: new challenges with the development ofinfluenza NA inhibitors

      REVIEWS IN MEDICAL VIROLOGY
    4. Gillet, R; Grimber, G; Bennoun, M; de Fromentel, CC; Briand, P; Joulin, V
      The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents

      ONCOGENE
    5. Fladerer, P; Wenisch, C
      Neuraminidase inhibitors in the therapy of influenza

      ACTA MEDICA AUSTRIACA
    6. Bolad, A; Berzins, K
      Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    7. McKimm-Breschkin, JL
      Resistance of influenza viruses to neuraminidase inhibitors - a review

      ANTIVIRAL RESEARCH
    8. Gubareva, LV; Kaiser, L; Hayden, FG
      Influenza virus neuraminidase inhibitors

      LANCET
    9. Barnett, JM; Cadman, A; Gor, D; Dempsey, M; Walters, M; Candlin, A; Tisdale, M; Morley, PJ; Owens, IJ; Fenton, RJ; Lewis, AP; Claas, ECJ; Rimmelzwaan, GF; De Groot, R; Osterhaus, ADME
      Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. Digits, JA; Hedstrom, L
      Drug selectivity is determined by coupling across the NAD(+) site of IMP dehydrogenase

      BIOCHEMISTRY
    11. Pai, VB; Nahata, MC
      Nelfinavir mesylate: A protease inhibitor

      ANNALS OF PHARMACOTHERAPY
    12. Kim, CU; Chen, XW; Mendel, DB
      Neuraminidase inhibitors as anti-influenza virus agents

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    13. Colman, PM
      A novel approach to antiviral therapy for influenza

      Journal of antimicrobial chemotherapy
    14. Bossi, P; Mouroux, M; Yvon, A; Bricaire, F; Agut, H; Huraux, JM; Katlama, C; Calvez, V
      Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor

      JOURNAL OF CLINICAL MICROBIOLOGY
    15. Air, GM; Ghate, AA; Stray, SJ
      Influenza neuraminidase as target for antivirals

      ADVANCES IN VIRUS RESEARCH, VOL 54
    16. Barnett, JM; Cadman, A; Burrell, FM; Madar, SH; Lewis, AP; Tisdale, M; Bethell, R
      In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

      VIROLOGY
    17. Rowley, KV; Harvey, R; Barclay, WS
      Isolation and characterization of a transfectant influenza B virus alteredin RNA segment 6

      JOURNAL OF GENERAL VIROLOGY
    18. MENDEL DB; SIDWELL RW
      INFLUENZA-VIRUS RESISTANCE TO NEURAMINIDASE INHIBITORS

      DRUG RESISTANCE UPDATES
    19. VARGHESE JN; SMITH PW; SOLLIS SL; BLICK TJ; SAHASRABUDHE A; MCKIMMBRESCHKIN JL; COLMAN PM
      DRUG DESIGN AGAINST A SHIFTING TARGET - A STRUCTURAL BASIS FOR RESISTANCE TO INHIBITORS IN A VARIANT OF INFLUENZA-VIRUS NEURAMINIDASE

      Structure
    20. SAEZLLORENS X; RAMILO O
      EARLY EXPERIENCE WITH PROTEASE INHIBITORS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

      The Pediatric infectious disease journal
    21. SHISHOVA YV; CHEKHUN VF
      THE MECHANISMS OF TUMOR RESISTANCE TO CIS PLATIN

      Eksperimental'naa onkologia
    22. WEBER IT; CAVANAUGH DS; HARRISON RW
      MODELS OF HIV-1 PROTEASE WITH PEPTIDES REPRESENTING ITS NATURAL SUBSTRATES

      Journal of molecular structure. Theochem
    23. Tai, CY; Escarpe, PA; Sidwell, RW; Williams, MA; Lew, W; Wu, HW; Kim, CU; Mendel, DB
      Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    24. SAHASRABUDHE A; LAWRENCE L; EPA VC; VARGHESE JN; COLMAN PM; MCKIMMBRESCHKIN JL
      SUBSTRATE, INHIBITOR, OR ANTIBODY STABILIZES THE GLU-119 GLY MUTANT INFLUENZA-VIRUS NEURAMINIDASE

      Virology (New York, N.Y. Print)
    25. BLICK TJ; SAHASRABUDHE A; MCDONALD M; OWENS IJ; MORLEY PJ; FENTON RJ; MCKIMMBRESCHKIN JL
      THE INTERACTION OF NEURAMINIDASE AND HEMAGGLUTININ MUTATIONS IN INFLUENZA-VIRUS IN RESISTANCE TO 4-GUANIDINO-NEU5AC2EN

      Virology (New York, N.Y. Print)
    26. CARRILLO A; STEWART KD; SHAM HL; NORBECK DW; KOHLBRENNER WE; LEONARD JM; KEMPF DJ; MOLLA A
      IN-VITRO SELECTION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED RESISTANCE TO ABT-378, A NOVEL PROTEASE INHIBITOR

      Journal of virology
    27. SMITH RA; REMINGTON KM; PRESTON BD; SCHINAZI RF; NORTH TW
      A NOVEL POINT MUTATION AT POSITION-156 OF REVERSE-TRANSCRIPTASE FROM FELINE IMMUNODEFICIENCY VIRUS CONFERS RESISTANCE TO THE COMBINATION OF(-)-BETA-2',3'-DIDEOXY-3'-THIACYTIDINE AND 3'-AZIDO-3'-DEOXYTHYMIDINE

      Journal of virology
    28. Ghate, AA; Air, GM
      Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    29. RIDKY TW; KIKONYOGO A; LEIS J
      DRUG-RESISTANT HIV-1 PROTEASES IDENTIFY ENZYME RESIDUES IMPORTANT FORSUBSTRATE SELECTION AND CATALYTIC RATE

      Biochemistry (Easton)
    30. POTTS KE; SMIDT ML; TUCKER SP; STIEBEL TR; MCDONALD JJ; STALLINGS WC; BRYANT ML
      IN-VITRO SEQUENTIAL SELECTION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH REDUCED SENSITIVITY TO HYDROXYETHYLUREA PROTEASE INHIBITORS

      Antiviral chemistry & chemotherapy
    31. TAYLOR DL; AHMED PS; BRENNAN TM; BRIDGES CG; TYMS AS; VANDORSSELAER V; TARNUS C; HORNSPERGER JM; SCHIRLIN D
      ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, BIOAVAILABILITY AND DRUG-RESISTANCE PROFILE OF THE NOVEL PROTEINASE-INHIBITOR MDL-74,695

      Antiviral chemistry & chemotherapy
    32. LACHANCE C; BELLIVEAU DT; BARKER PA
      BLOCKING NERVE GROWTH-FACTOR BINDING TO THE P75 NEUROTROPHIN RECEPTORON SYMPATHETIC NEURONS TRANSIENTLY REDUCES TRKA ACTIVATION BUT DOES NOT AFFECT NEURONAL SURVIVAL

      Neuroscience
    33. GOTO H; BETHELL RC; KAWAOKA Y
      MUTATIONS AFFECTING THE SENSITIVITY OF THE INFLUENZA-VIRUS NEURAMINIDASE TO ANIDINO-2,4-DIDEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID

      Virology
    34. COLACINO JM; CHIRGADZE NY; GARMAN E; MURTI KG; LONCHARICH RJ; BAXTER AJ; STASCHKE KA; LAVER WG
      A SINGLE SEQUENCE CHANGE DESTABILIZES THE INFLUENZA-VIRUS NEURAMINIDASE TETRAMER

      Virology
    35. SHAO W; EVERITT L; MANCHESTER M; LOEB DD; HUTCHISON CA; SWANSTROM R
      SEQUENCE REQUIREMENTS OF THE HIV-1 PROTEASE FLAP REGION DETERMINED BYSATURATION MUTAGENESIS AND KINETIC-ANALYSIS OF FLAP MUTANTS

      Proceedings of the National Academy of Sciences of the United Statesof America
    36. SMITH RA; REMINGTON KM; LLOYD RM; SCHINAZI R; NORTH TW
      A NOVEL MET-TO-THR MUTATION IN THE YMDD MOTIF OF REVERSE-TRANSCRIPTASE FROM FELINE IMMUNODEFICIENCY VIRUS CONFERS RESISTANCE TO OXATHIOLANENUCLEOSIDES

      Journal of virology
    37. JADHAV PK; ALA P; WOERNER FJ; CHANG CH; GARBER SS; ANTON ED; BACHELER LT
      CYCLIC UREA AMIDES - HIV-1 PROTEASE INHIBITORS WITH LOW NANOMOLAR POTENCY AGAINST BOTH WILD-TYPE AND PROTEASE INHIBITOR RESISTANT MUTANTS OF HIV

      Journal of medicinal chemistry
    38. ALA PJ; HUSTON EE; KLABE RM; MCCABE DD; DUKE JL; RIZZO CJ; KORANT BD; DELOSKEY RJ; LAM PYS; HODGE CN; CHANG CH
      MOLECULAR-BASIS OF HIV-1 PROTEASE DRUG-RESISTANCE - STRUCTURAL-ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH CYCLIC UREA INHIBITORS

      Biochemistry
    39. TOWLER EM; THOMPSON SK; TOMASZEK T; DEBOUCK C
      IDENTIFICATION OF A LOOP OUTSIDE THE ACTIVE-SITE CAVITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASES WHICH CONFERS INHIBITOR SPECIFICITY

      Biochemistry
    40. MCDONALD CK; KURITZKES DR
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS

      Archives of internal medicine
    41. TSCHIDA SJ; GRAUPE KJ; HOEY LL; VANCEBRYAN K
      RESISTANCE TO NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS

      Pharmacotherapy
    42. ZHU YQ; REMINGTON KM; NORTH TW
      MUTANTS OF FELINE IMMUNODEFICIENCY VIRUS RESISTANT TO 2',3'-DIDEOXY-2',3'-DIDEHYDROTHYMIDINE

      Antimicrobial agents and chemotherapy
    43. VASUDEVACHARI MB; ZHANG YM; IMAMICHI H; IMAMICHI T; FALLOON J; SALZMAN NP
      EMERGENCE OF PROTEASE INHIBITOR RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS AND RAPID SCREENING-PROCEDURE FOR THEIR DETECTION

      Antimicrobial agents and chemotherapy
    44. CONDRA JH; HOLDER DJ; SCHLEIF WA; BLAHY OM; DANOVICH RM; GABRYELSKI LJ; GRAHAM DJ; LAIRD D; QUINTERO JC; RHODES A; ROBBINS HL; ROTH E; SHIVAPRAKASH M; YANG T; CHODAKEWITZ JA; DEUTSCH PJ; LEAVITT RY; MASSARI FE; MELLORS JW; SQUIRES KE; STEIGBIGEL RT; TEPPLER H; EMINI EA
      GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR

      Journal of virology
    45. MASCHERA B; DARBY G; PALU G; WRIGHT LL; TISDALE M; MYERS R; BLAIR ED; FURFINE ES
      HUMAN-IMMUNODEFICIENCY-VIRUS - MUTATIONS IN THE VIRAL PROTEASE THAT CONFER RESISTANCE TO SAQUINAVIR INCREASE THE DISSOCIATION RATE-CONSTANTOF THE PROTEASE-SAQUINAVIR COMPLEX

      The Journal of biological chemistry
    46. SCHOCK HB; GARSKY VM; KUO LC
      MUTATIONAL ANATOMY OF AN HIV-1 PROTEASE VARIANT CONFERRING CROSS-RESISTANCE TO PROTEASE INHIBITORS IN CLINICAL-TRIALS - COMPENSATORY MODULATIONS OF BINDING AND ACTIVITY

      The Journal of biological chemistry
    47. JELINEK T; SCHELBERT P; LOSCHER T; EICHENLAUB D
      QUININE RESISTANT FALCIPARUM-MALARIA ACQUIRED IN EAST-AFRICA

      Tropical medicine and parasitology
    48. FUNG DL; WHITE DA; GRONERT GA; DISBROW E
      THE CHANGING PHARMACODYNAMICS OF METOCURINE IDENTIFY THE ONSET AND OFFSET OF CANINE GASTROCNEMIUS DISUSE ATROPHY

      Anesthesiology
    49. MELTON AT; ANTOGNINI JF; GRONERT GA
      PROLONGED DURATION OF SUCCINYLCHOLINE IN PATIENTS RECEIVING ANTICONVULSANTS - EVIDENCE FOR MILD UP-REGULATION OF ACETYLCHOLINE-RECEPTORS

      Canadian journal of anaesthesia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:26:33